Cargando…
Recommendation for optimal management of severe refractory asthma
Patients whose asthma is not adequately controlled despite treatment with a combination of high dose inhaled corticosteroids and long-acting bronchodilators pose a major clinical challenge and an important health care problem. Patients with severe refractory disease often require regular oral cortic...
Autores principales: | Morjaria, Jaymin B, Polosa, Riccardo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047913/ https://www.ncbi.nlm.nih.gov/pubmed/21437039 |
Ejemplares similares
-
Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience
por: Emma, Rosalia, et al.
Publicado: (2018) -
Dupilumab and tezepelumab in severe refractory asthma: new opportunities
por: Ragnoli, Beatrice, et al.
Publicado: (2022) -
Optimal Management of Severe/Refractory Asthma
por: Pakhale, Smita, et al.
Publicado: (2011) -
Success rates with nicotine personal vaporizers: a prospective 6-month pilot study of smokers not intending to quit
por: Polosa, Riccardo, et al.
Publicado: (2014) -
Symptoms and exacerbations in asthma: an apparent paradox?
por: Morjaria, Jaymin B., et al.
Publicado: (2019)